Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Dodson

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Molecular Oncology|February 20, 2022
CHML is an NRF2 target gene that regulates mTOR functionMatthew Dodson, Wujing Dai, Annadurai Anandhan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2018
RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE-dependent repressionPengfei Liu, Montserrat Rojo de la Vega, Saad Sammani, et al.
Current Pharmacology Reports|June 18, 2016
Role of Nrf2 and Autophagy in Acute Lung InjuryMontserrat Rojo de la Vega, Matthew Dodson, Christine Gross, et al.
Molecular Metabolism|May 2, 2021
Non-canonical NRF2 activation promotes a pro-diabetic shift in hepatic glucose metabolismPengfei Liu, Matthew Dodson, Hui Li, et al.
Science Advances|February 1, 2023
NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8Annadurai Anandhan, Matthew Dodson, Aryatara Shakya, et al.
The Prostate|August 24, 2016
Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate CancerBalabhadrapatruni V S K Chakravarthi, Moloy T Goswami, Satya S Pathi, et al.
The Prostate|May 11, 2018
Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancerBalabhadrapatruni V S K Chakravarthi, Moloy T Goswami, Satya S Pathi, et al.
Journal of Medicinal Chemistry|October 22, 2021
Discovery of an eIF4A Inhibitor with a Novel Mechanism of ActionChristopher J Zerio, Tyler A Cunningham, Allison S Tulino, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Molecular Oncology|February 20, 2022
CHML is an NRF2 target gene that regulates mTOR functionMatthew Dodson, Wujing Dai, Annadurai Anandhan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2018
RPA1 binding to NRF2 switches ARE-dependent transcriptional activation to ARE-NRE-dependent repressionPengfei Liu, Montserrat Rojo de la Vega, Saad Sammani, et al.
Current Pharmacology Reports|June 18, 2016
Role of Nrf2 and Autophagy in Acute Lung InjuryMontserrat Rojo de la Vega, Matthew Dodson, Christine Gross, et al.
Molecular Metabolism|May 2, 2021
Non-canonical NRF2 activation promotes a pro-diabetic shift in hepatic glucose metabolismPengfei Liu, Matthew Dodson, Hui Li, et al.
Science Advances|February 1, 2023
NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8Annadurai Anandhan, Matthew Dodson, Aryatara Shakya, et al.
The Prostate|August 24, 2016
Expression and Role of PAICS, a De Novo Purine Biosynthetic Gene in Prostate CancerBalabhadrapatruni V S K Chakravarthi, Moloy T Goswami, Satya S Pathi, et al.
The Prostate|May 11, 2018
Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancerBalabhadrapatruni V S K Chakravarthi, Moloy T Goswami, Satya S Pathi, et al.
Journal of Medicinal Chemistry|October 22, 2021
Discovery of an eIF4A Inhibitor with a Novel Mechanism of ActionChristopher J Zerio, Tyler A Cunningham, Allison S Tulino, et al.
Pageof 5